NO20003229D0 - Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer - Google Patents

Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer

Info

Publication number
NO20003229D0
NO20003229D0 NO20003229A NO20003229A NO20003229D0 NO 20003229 D0 NO20003229 D0 NO 20003229D0 NO 20003229 A NO20003229 A NO 20003229A NO 20003229 A NO20003229 A NO 20003229A NO 20003229 D0 NO20003229 D0 NO 20003229D0
Authority
NO
Norway
Prior art keywords
treatment
combination
proliferative diseases
antineoplastic drugs
benzocycloheptapyridine
Prior art date
Application number
NO20003229A
Other languages
English (en)
Other versions
NO326832B1 (no
NO20003229L (no
Inventor
Walter R Bishop
Joseph J Catino
Ronald J Doll
Ashit Ganguly
Viyyoor Moopil Girijavallabhan
Paul Kirschmeier
Ming Liu
Loretta L Nielsen
David L Cutler
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27385940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003229(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20003229D0 publication Critical patent/NO20003229D0/no
Publication of NO20003229L publication Critical patent/NO20003229L/no
Publication of NO326832B1 publication Critical patent/NO326832B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20003229A 1997-12-22 2000-06-21 Kombinasjon av benzosykloheptapyridinforbindelser og et antineoplastisk midel for fremstilling av et medikament for behandling av proliferative sykdommer. NO326832B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US99602797A 1997-12-22 1997-12-22
US14352998A 1998-08-28 1998-08-28
US18196998A 1998-10-29 1998-10-29
PCT/US1998/026224 WO1999032114A1 (en) 1997-12-22 1998-12-21 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases

Publications (3)

Publication Number Publication Date
NO20003229D0 true NO20003229D0 (no) 2000-06-21
NO20003229L NO20003229L (no) 2000-08-22
NO326832B1 NO326832B1 (no) 2009-02-23

Family

ID=27385940

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003229A NO326832B1 (no) 1997-12-22 2000-06-21 Kombinasjon av benzosykloheptapyridinforbindelser og et antineoplastisk midel for fremstilling av et medikament for behandling av proliferative sykdommer.

Country Status (25)

Country Link
EP (1) EP1041985B1 (no)
JP (1) JP4502503B2 (no)
KR (1) KR100700907B1 (no)
CN (1) CN1129431C (no)
AR (1) AR017440A1 (no)
AT (1) ATE317697T1 (no)
AU (1) AU756762B2 (no)
BR (1) BR9814419A (no)
CA (1) CA2315693C (no)
CL (1) CL2007001889A1 (no)
CO (1) CO5080764A1 (no)
CZ (1) CZ298511B6 (no)
DE (1) DE69833509T2 (no)
DK (1) DK1041985T3 (no)
ES (1) ES2255196T3 (no)
HU (1) HUP0102473A3 (no)
IL (1) IL136462A0 (no)
MY (1) MY137303A (no)
NO (1) NO326832B1 (no)
NZ (1) NZ504928A (no)
PE (1) PE20000042A1 (no)
PT (1) PT1041985E (no)
SK (1) SK285584B6 (no)
TW (1) TW581763B (no)
WO (1) WO1999032114A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787327B1 (fr) * 1998-12-21 2003-01-17 Aventis Pharma Sa Compositions contenant des inhibiteurs de farnesyle transferase
PT1233787E (pt) * 1999-11-09 2005-04-29 Conseils Rech S Et D Applic Sc Produto contendo um inibidor da transducao dos sinais das proteinas g heterotrimericas em associacao com um outro agente anticanceroso para utilizacao terapeutica no tratamento do cancro
AU2292801A (en) * 1999-12-22 2001-07-03 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Compositions and methods for treatment of breast cancer
CA2397690A1 (en) * 2000-02-29 2001-09-07 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
CA2397256A1 (en) * 2000-02-29 2001-09-07 Mary Ellen Margaret Rybak Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
AU2001242434A1 (en) * 2000-02-29 2001-09-12 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with vinca alkaloids
JP2003525237A (ja) * 2000-02-29 2003-08-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗腫瘍性アントラサイクリン誘導体とのファルネシルタンパク質トランスフェラーゼ阻害剤組み合わせ剤
WO2001064217A2 (en) * 2000-02-29 2001-09-07 Janssen Pharmaceutica N.V. Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents
AU2001246477A1 (en) * 2000-02-29 2001-09-12 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with platinum compounds
TWI310684B (en) 2000-03-27 2009-06-11 Bristol Myers Squibb Co Synergistic pharmaceutical kits for treating cancer
AU2002236813A1 (en) * 2001-01-22 2002-07-30 Schering Corporation Treatment of malaria with farnesyl protein transferase inhibitors
WO2002064142A1 (en) * 2001-02-15 2002-08-22 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with antiestrogen agents
WO2003047697A2 (en) * 2001-11-30 2003-06-12 Schering Corporation Use of an farsenyl protein tranferase inhibitor in combination with other antineoplastic agents for the manufacture of a medicament against cancer
EP1453513A1 (en) * 2001-12-03 2004-09-08 Schering Corporation Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
CN105198758A (zh) * 2015-09-22 2015-12-30 湖南大学 一种高纯度(z)-他莫昔酚的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
DE69120430D1 (de) * 1990-12-18 1996-07-25 Wellcome Found Mittel zur verstaerkung der wirkung von antitumoralen mittel und zur widerstandsbekaempfung von vielfachdrogen
JP2767176B2 (ja) * 1992-12-15 1998-06-18 大塚製薬株式会社 抗癌剤
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
DE69635114T2 (de) * 1995-08-09 2006-03-02 Banyu Pharmaceutical Co., Ltd. Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids
SK86198A3 (en) * 1995-12-22 1999-02-11 Schering Corp Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
PL189698B1 (pl) * 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
WO1997036583A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0910385A4 (en) * 1996-04-15 1999-12-22 Univ Pennsylvania Sensitization of cells to radiation and chemotherapy
WO1997038664A2 (en) * 1996-04-18 1997-10-23 Merck & Co., Inc. A method of treating cancer
AU3215197A (en) * 1996-05-30 1998-01-05 Merck & Co., Inc. A method of treating cancer
US6337992B1 (en) * 1997-01-29 2002-01-08 Philips Medical Systems Technologies Ltd. Predictive bolus tracking
DE69837754T2 (de) * 1997-02-18 2008-02-07 Canji, Inc., San Diego Kombinierte tumor suppressor-gen-therapie und chemotherapie bei der neoplasmabehandlung

Also Published As

Publication number Publication date
HUP0102473A2 (hu) 2002-01-28
HUP0102473A3 (en) 2003-07-28
DE69833509D1 (de) 2006-04-20
ES2255196T3 (es) 2006-06-16
CL2007001889A1 (es) 2008-01-11
CA2315693C (en) 2010-11-30
SK285584B6 (sk) 2007-04-05
EP1041985B1 (en) 2006-02-15
CN1284875A (zh) 2001-02-21
CO5080764A1 (es) 2001-09-25
IL136462A0 (en) 2001-06-14
CN1129431C (zh) 2003-12-03
WO1999032114A1 (en) 1999-07-01
CZ20002236A3 (cs) 2001-04-11
AU756762B2 (en) 2003-01-23
SK8982000A3 (en) 2001-04-09
MY137303A (en) 2009-01-30
TW581763B (en) 2004-04-01
PT1041985E (pt) 2006-07-31
PE20000042A1 (es) 2000-02-17
BR9814419A (pt) 2000-10-10
CA2315693A1 (en) 1999-07-01
KR100700907B1 (ko) 2007-03-29
KR20010033452A (ko) 2001-04-25
NO326832B1 (no) 2009-02-23
JP4502503B2 (ja) 2010-07-14
DK1041985T3 (da) 2006-06-19
DE69833509T2 (de) 2006-10-26
NZ504928A (en) 2004-12-24
CZ298511B6 (cs) 2007-10-24
EP1041985A1 (en) 2000-10-11
NO20003229L (no) 2000-08-22
ATE317697T1 (de) 2006-03-15
AR017440A1 (es) 2001-09-05
AU1907299A (en) 1999-07-12
JP2001526224A (ja) 2001-12-18

Similar Documents

Publication Publication Date Title
IS5500A (is) Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum
NO971015L (no) Forbindelser og metoder for behandling av cancer
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
NO974610L (no) Trisykliske forbindelser som er anvendbare for inhibering av G-proteinfunksjon og for behandling av proliferative sykdommer
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO20063000L (no) Kombinasjon og farmasøytisk blanding for behandling av diabetes samt anvendelse derav.
NO20001775L (no) Munnhygienepreparat til behandling av halitose
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
NO20005885D0 (no) Kombinasjonsterapi for behandling av refraktær depresjon
EP1385465A4 (en) HETEROCYCLIC DERIVATIVE FOR THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES
NO20003229L (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer
NO20002189L (no) Anvendelse av makrolider for behandling av cancer og mukuladegenerasjon
NO20005179D0 (no) Medikament behandling
EE9600139A (et) Farmatseutilised preparaadid ja ravimid endoteelsete düsfunktsioonide vältimiseks ja raviks
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
NO307930B1 (no) Benzo[f]kinolinoner, farmasøytisk formulering omfattende samme og anvendelse av samme for fremstilling av formulering for behandling
DE4494713T1 (de) Arylsulfonamidderivate und diese Derivate enthaltende Arzneimittel
NO20012106D0 (no) Middel for behandling av benpatobolisme
FI971527L (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
IL115320A0 (en) Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
DK0879054T3 (da) Anvendelse af pyrrolidionderivater til fremstilling af medikamenter til behandling af narkotikamisbrug
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees